SILO Pharma (SILO) Gains 53%
For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun.
Silo Pharma Gains 53%...
Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update
$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024
Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.
If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term,...
Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.
Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super...
Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.
Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided...
Latest article
Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...
GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...
Adding Allarity (ALLR) $0.70, to Watch List.
LIVE QUOTE
SHORT TERM CHART
Bargain Hunting?
Adding to the...
